ArTara Therapeutics, Inc. (TARA)
Last Price: 
Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ArTara Therapeutics, Inc. (TARA) had Weighted-Average Shares Outstanding (Diluted) of 6.32M for the most recently reported fiscal quarter, ending 2020-09-30.
| Income Statement Financials | |
-- |
|
$-7.97M |
|
-- |
|
-- |
|
$8.06M |
|
$-8.06M |
|
$0.09M |
|
$-7.97M |
|
$-7.97M |
|
$-7.97M |
|
$-7.97M |
|
$-7.97M |
|
$-7.97M |
|
$-8.06M |
|
$-8.01M |
|
6.32M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
6.32M |
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$167.12M |
|
$0.76M |
|
$31.79M |
|
$198.91M |
|
$3.89M |
|
-- |
|
$0.39M |
|
$4.28M |
|
$194.63M |
|
$165.26M |
|
$194.63M |
|
10.52M |
|
| Cash Flow Statement Financials | |
$-16.64M |
|
$3.35M |
|
$178.69M |
|
$0.56M |
|
$165.95M |
|
$165.39M |
|
$7.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
43.00 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.10% |
|
-4.82% |
|
-4.01% |
|
-4.10% |
|
$18.50 |
|
$-2.69 |
|
$-2.63 |
|